BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 2560273)

  • 1. Invasive adenylate cyclase toxin of Bordetella pertussis.
    Hanski E
    Trends Biochem Sci; 1989 Nov; 14(11):459-63. PubMed ID: 2560273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenylate cyclase toxin from Bordetella pertussis. Identification and purification of the holotoxin molecule.
    Hewlett EL; Gordon VM; McCaffery JD; Sutherland WM; Gray MC
    J Biol Chem; 1989 Nov; 264(32):19379-84. PubMed ID: 2553737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bordetella pertussis adenylate cyclase toxin: intoxication of host cells by bacterial invasion.
    Mouallem M; Farfel Z; Hanski E
    Infect Immun; 1990 Nov; 58(11):3759-64. PubMed ID: 2172167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of adenylate cyclase toxin from a mutant of Bordetella pertussis defective in the activator gene, cyaC.
    Hewlett EL; Gray MC; Ehrmann IE; Maloney NJ; Otero AS; Gray L; Allietta M; Szabo G; Weiss AA; Barry EM
    J Biol Chem; 1993 Apr; 268(11):7842-8. PubMed ID: 8385122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenylate cyclase toxin from Bordetella pertussis. The relationship between induction of cAMP and hemolysis.
    Rogel A; Meller R; Hanski E
    J Biol Chem; 1991 Feb; 266(5):3154-61. PubMed ID: 1847141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of temperature and host factors on the activities of pertussis toxin and Bordetella adenylate cyclase.
    Murayama T; Hewlett EL; Maloney NJ; Justice JM; Moss J
    Biochemistry; 1994 Dec; 33(51):15293-7. PubMed ID: 7803392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bordatella pertussis adenylate cyclase: a toxin with multiple talents.
    Ladant D; Ullmann A
    Trends Microbiol; 1999 Apr; 7(4):172-6. PubMed ID: 10217833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of platelet aggregation by Bordetella pertussis adenylate cyclase toxin.
    Iwaki M; Kamachi K; Heveker N; Konda T
    Infect Immun; 1999 Jun; 67(6):2763-8. PubMed ID: 10338478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bordetella pertussis adenylate cyclase: purification and characterization of the toxic form of the enzyme.
    Rogel A; Schultz JE; Brownlie RM; Coote JG; Parton R; Hanski E
    EMBO J; 1989 Sep; 8(9):2755-60. PubMed ID: 2555185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bordetella pertussis adenylate cyclase: effects of affinity-purified adenylate cyclase on human polymorphonuclear leukocyte functions.
    Friedman RL; Fiederlein RL; Glasser L; Galgiani JN
    Infect Immun; 1987 Jan; 55(1):135-40. PubMed ID: 2878884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bordetella pertussis adenylate cyclase: isolation and purification by calmodulin-sepharose 4B chromatography.
    Friedman RL
    Infect Immun; 1987 Jan; 55(1):129-34. PubMed ID: 2878883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bordetella pertussis adenylate cyclase. Penetration into host cells.
    Gentile F; Raptis A; Knipling LG; Wolff J
    Eur J Biochem; 1988 Aug; 175(3):447-53. PubMed ID: 2900763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of adenylate cyclase toxin from Bordetella pertussis on human neutrophil interactions with Coccidioides immitis and Staphylococcus aureus.
    Galgiani JN; Hewlett EL; Friedman RL
    Infect Immun; 1988 Apr; 56(4):751-5. PubMed ID: 2894360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The calmodulin-sensitive adenylate cyclase of Bordetella pertussis: cloning and expression in Escherichia coli.
    Glaser P; Ladant D; Sezer O; Pichot F; Ullmann A; Danchin A
    Mol Microbiol; 1988 Jan; 2(1):19-30. PubMed ID: 2897067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bordetella pertussis adenylate cyclase toxin. Structural and functional independence of the catalytic and hemolytic activities.
    Sakamoto H; Bellalou J; Sebo P; Ladant D
    J Biol Chem; 1992 Jul; 267(19):13598-602. PubMed ID: 1618862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Major Toxin Virulence Factors in Pertussis Infection and Disease Pathogenesis.
    Scanlon K; Skerry C; Carbonetti N
    Adv Exp Med Biol; 2019; 1183():35-51. PubMed ID: 31376138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A particular class of virulence factors: calmodulin-activated bacterial adenylate cyclases.
    Ullmann A; Mock M
    Zentralbl Bakteriol; 1994 Oct; 281(3):284-95. PubMed ID: 7696748
    [No Abstract]   [Full Text] [Related]  

  • 18. Calmodulin inhibits entry of Bordetella pertussis adenylate cyclase into animal cells.
    Shattuck RL; Storm DR
    Biochemistry; 1985 Nov; 24(23):6323-8. PubMed ID: 2867777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of binding of adenylate cyclase toxin to target cells by flow cytometry.
    Gray MC; Ross W; Kim K; Hewlett EL
    Infect Immun; 1999 Sep; 67(9):4393-9. PubMed ID: 10456879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane depolarization prevents cell invasion by Bordetella pertussis adenylate cyclase toxin.
    Otero AS; Yi XB; Gray MC; Szabo G; Hewlett EL
    J Biol Chem; 1995 Apr; 270(17):9695-7. PubMed ID: 7730345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.